Somatropin (Genotropin) for subcutaneous injection long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone

The objective of this systematic review is to compare the benefits and harms of Genotropin with other available somatropin products in children with growth hormone deficiency (GHD)

Bibliographic Details
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2014, 2014
Series:Common drug review clinical review report
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The objective of this systematic review is to compare the benefits and harms of Genotropin with other available somatropin products in children with growth hormone deficiency (GHD)
Item Description:Title from title screen
Physical Description:1 online resource illustrations